These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19579793)

  • 1. Influence of conformational antibodies on dissociation of fibrillar amyloid beta (A beta 1-42) in vitro.
    Subramanian S; Madhavadas S; Balasubramanian P
    Indian J Exp Biol; 2009 May; 47(5):309-13. PubMed ID: 19579793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prion protein epitope selective for the pathologically misfolded conformation.
    Paramithiotis E; Pinard M; Lawton T; LaBoissiere S; Leathers VL; Zou WQ; Estey LA; Lamontagne J; Lehto MT; Kondejewski LH; Francoeur GP; Papadopoulos M; Haghighat A; Spatz SJ; Head M; Will R; Ironside J; O'Rourke K; Tonelli Q; Ledebur HC; Chakrabartty A; Cashman NR
    Nat Med; 2003 Jul; 9(7):893-9. PubMed ID: 12778138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological activity of human single-chain antibody against amyloid beta peptide involved in Alzheimer's disease].
    Cai J; Li F; Liu F; Wang SZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):647-50. PubMed ID: 18051722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of phage library-derived human single-chain antibodies to amyloid beta conformers in vitro.
    Yoshihara T; Takiguchi S; Kyuno A; Tanaka K; Kuba S; Hashiguchi S; Ito Y; Hashimoto T; Iwatsubo T; Tsuyama S; Nakashima T; Sugimura K
    J Biochem; 2008 Apr; 143(4):475-86. PubMed ID: 18174189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformation-dependent anti-amyloid oligomer antibodies.
    Kayed R; Glabe CG
    Methods Enzymol; 2006; 413():326-44. PubMed ID: 17046404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
    Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
    Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of recombinantly expressed and cytotoxic human amyloid-beta peptide 1-42.
    Wiesehan K; Funke SA; Fries M; Willbold D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):229-33. PubMed ID: 17606418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of vaccination approaches for the treatment of neurological diseases.
    Federoff HJ
    J Comp Neurol; 2009 Jul; 515(1):4-14. PubMed ID: 19399901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.
    van Helmond Z; Heesom K; Love S
    J Neurosci Methods; 2009 Jan; 176(2):206-12. PubMed ID: 18824027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide.
    Istrin G; Bosis E; Solomon B
    J Neurosci Res; 2006 Aug; 84(2):434-43. PubMed ID: 16767774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, structural, and immuno-analytical properties of antigenic bioconjugates comprising a beta-amyloid-plaque specific epitope.
    Manea M; Przybylski M; Hudecz F; Mezö G
    Biopolymers; 2008; 90(2):94-104. PubMed ID: 18183582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases.
    Leliveld SR; Korth C
    J Neurosci Res; 2007 Aug; 85(11):2285-97. PubMed ID: 17497676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for modulators of aggregation with a microplate elongation assay.
    Berthelier V; Wetzel R
    Methods Enzymol; 2006; 413():313-25. PubMed ID: 17046403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-dependent antibodies target diseases of protein misfolding.
    Glabe CG
    Trends Biochem Sci; 2004 Oct; 29(10):542-7. PubMed ID: 15450609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific reactivity of mild/severe Alzheimer's disease patient's sera to antibody against Abeta1-40 epitope 17-21.
    Bolukbasi Hatip FF; Matsunaga Y; Yamada T
    Acta Neurol Scand; 2008 Jun; 117(6):404-8. PubMed ID: 18005218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conformational change, pore formation and neurotoxicity of amyloidogenic proteins].
    Kawahara M
    Rinsho Byori; 2008 Feb; 56(2):130-6. PubMed ID: 18404827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures and thermodynamics of Alzheimer's amyloid-beta Abeta(16-35) monomer and dimer by replica exchange molecular dynamics simulations: implication for full-length Abeta fibrillation.
    Chebaro Y; Mousseau N; Derreumaux P
    J Phys Chem B; 2009 May; 113(21):7668-75. PubMed ID: 19415895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.